Luo Moulun, Mengos April E, Stubblefield Tianna M, Mandarino Lawrence J
Center for Metabolic and Vascular Biology, Mayo Clinic Arizona, Scottsdale, Arizona; Arizona State University, Tempe, Arizona, USA.
Department of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
J Proteomics Bioinform. 2012;5(3):60-66. doi: 10.4172/jpb.1000214. Epub 2012 Feb 29.
Nonalcoholic fatty liver disease (NAFLD) is associated with obesity, insulin resistance, type 2 diabetes, and dyslipidemia. The purpose of this study was to identify novel proteins and pathways that contribute to the pathogenesis and complications of NAFLD. C57BL/6J male mice were fed a 60% (HFD) or 10% (LFD) high or low fat diet. HFD induced obesity, hepatic steatosis and insulin resistance (euglycemic clamps, glucose infusion rate: LFD 50.5 ± 6.4 vs. HFD 14.2 ± 9.5 μg/ (g·min); = 12). Liver proteins were analyzed by mass spectrometry-based proteomics analysis. Numerous hepatic proteins were altered in abundance after 60% HFD feeding. Nine down-regulated and nine up-regulated proteins were selected from this list for detailed analysis based on the criteria of 1.5-fold difference, consistency across replicates, and having at least 2 spectra assigned. Proteins that decreased in abundance were acyl-coA desaturase-I (SCD-1), acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), pyruvate kinase isozymes R/L (PKLR), NADP-dependent malic enzyme (ME-1), ATP-citrate synthase (ACL), ketohexokinase (KHK), long-chain-fatty acid-CoA ligase-5 (ACSL-5) and carbamoyl-phosphate synthase-I (CPS-1). Those that increased were KIAA0564, apolipoprotein A-I (apoA-1), ornithine aminotransferase (OAT), multidrug resistance protein 2 (MRP-2), liver carboxylesterase-I (CES-1), aminopeptidase N (APN), fatty aldehyde dehydrogenase (FALDH), major urinary protein 2 (MUP-2) and KIAA0664. KIAA0564 and KIAA0664 proteins are uncharacterized and are novel proteins associated with NAFLD. The decreased abundance of normally highly abundant proteins like FAS and CPS-1 was confirmed by Coomassie Blue staining after bands were identified by MS/MS, and immunoblot analysis confirmed the increased abundance of KIAA0664 after 60% HFD feeding. In conclusion, this study shows NAFLD is characterized by changes in abundance of proteins related to cell injury, inflammation, and lipid metabolism. Two novel and uncharacterized proteins, KIAA0564 and KIAA0664, may provide insight into the pathogenesis of NAFLD induced by lipid oversupply.
非酒精性脂肪性肝病(NAFLD)与肥胖、胰岛素抵抗、2型糖尿病和血脂异常有关。本研究的目的是确定导致NAFLD发病机制和并发症的新蛋白质和信号通路。给C57BL/6J雄性小鼠喂食60%(高脂饮食,HFD)或10%(低脂饮食,LFD)的高脂肪或低脂肪饮食。高脂饮食诱发了肥胖、肝脏脂肪变性和胰岛素抵抗(正常血糖钳夹,葡萄糖输注速率:低脂饮食组为50.5±6.4,高脂饮食组为14.2±9.5μg/(g·min);n = 12)。通过基于质谱的蛋白质组学分析对肝脏蛋白质进行分析。喂食60%高脂饮食后,大量肝脏蛋白质的丰度发生了改变。根据1.5倍差异、重复样本间的一致性以及至少有2个质谱峰归属的标准,从该列表中选择了9个下调和9个上调的蛋白质进行详细分析。丰度降低的蛋白质有酰基辅酶A去饱和酶-I(SCD-1)、乙酰辅酶A羧化酶(ACC)、脂肪酸合酶(FAS)、丙酮酸激酶同工酶R/L(PKLR)、NADP依赖性苹果酸酶(ME-1)、ATP-柠檬酸合酶(ACL)、己糖激酶(KHK)、长链脂肪酸辅酶A连接酶-5(ACSL-5)和氨甲酰磷酸合酶-I(CPS-1)。丰度增加的蛋白质有KIAA0564、载脂蛋白A-I(apoA-1)、鸟氨酸转氨酶(OAT)、多药耐药蛋白2(MRP-2)、肝脏羧酸酯酶-I(CES-1)、氨肽酶N(APN)、脂肪醛脱氢酶(FALDH)、主要尿蛋白2(MUP-2)和KIAA0664。KIAA0564和KIAA0664蛋白尚未被鉴定,是与NAFLD相关的新蛋白质。通过MS/MS鉴定条带后,考马斯亮蓝染色证实了正常情况下高丰度蛋白质如FAS和CPS-1的丰度降低,免疫印迹分析证实了喂食60%高脂饮食后KIAA0664的丰度增加。总之,本研究表明NAFLD的特征是与细胞损伤、炎症和脂质代谢相关的蛋白质丰度发生变化。两种新的未被鉴定的蛋白质KIAA0564和KIAA0664可能为深入了解脂质供应过多诱发的NAFLD的发病机制提供线索。